At the present time, the clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein 9 (Cas9) system has been widely adopted as an efficient genomic editing tool. However, there are some actual problems such as the off-target effects, cytotoxicity, and immunogenicity. The incorporation of modifications into guide RNAs permits enhancing both the efficiency and the specificity of the CRISPR-Cas9 system. In this study, we demonstrate that the inclusion of N6-methyladenosine, 5-methylcytidine, and pseudouridine in trans-activating RNA (tracrRNA) or in single guide RNA (sgRNA) enables efficient gene editing in vitro. We found that the complexes of modified guide RNAs with Cas9 protein promoted cleavage of the target short/long duplexes and plasmid substrates. In addition, the modified monomers in guide RNAs allow increasing the specificity of CRISPR-Cas9 system in vitro and promote diminishing both the immunostimulating and the cytotoxic effects of sgRNAs.
Get full access to this article
View all access options for this article.
References
1.
JiangF, DoudnaJA. CRISPR-Cas9 structures and mechanisms. Annu Rev Biophys, 2017; 46:505–529; doi: 10.1146/annurev-biophys-062215-010822
2.
JinekM, ChylinskiK, FonfaraI, et al.A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science, 2012; 337(6096):816–821; doi: 10.1126/science.1225829
3.
FilippovaJ, MatveevaA, ZhuravlevE, et al.Guide RNA modification as a way to improve CRISPR/Cas9-based genome-editing systems. Biochimie, 2019; 167:49–60; doi: 10.1016/j.biochi.2019.09.003
4.
DoudnaJA, CharpentierE. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science, 2014; 346(6213):1258096; doi: 10.1126/science.1258096
5.
FuY, FodenJA, KhayterC, et al.High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol, 2013; 31(9):822–826; doi: 10.1038/nbt.2623
6.
HsuPD, ScottDA, WeinsteinJA, et al.DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol, 2013; 31(9):827–832; doi: 10.1038/nbt.2647
7.
PattanayakV, LinS, GuilingerJP, et al.High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity. Nat Biotechnol, 2013; 31(9):839–843; doi: 10.1038/nbt.2673
8.
WangQ, LiuJ, JanssenJM, et al.Precise and broad scope genome editing based on high-specificity Cas9 nickases. Nucleic Acids Res, 2021; 49(2):1173–1198; doi: 10.1093/nar/gkaa1236
9.
KimN, KimHK, LeeS, et al.Prediction of the sequence-specific cleavage activity of Cas9 variants. Nat Biotechnol, 2020; 38(11):1328–1336; doi: 10.1038/s41587-020-0537-9
10.
PauschP, Al-ShayebB, Bisom-RappE, et al.CRISPR-CasΦ from huge phages is a hypercompact genome editor. Science, 2020; 369(6501):333–337; doi: 10.1126/science.abb1400
11.
HuJH, MillerSM, GeurtsMH, et al.Evolved Cas9 variants with broad PAM compatibility and high DNA specificity. Nature, 2018; 556(7699):57–63; doi: 10.1038/nature26155
12.
GopalappaR, SureshB, RamakrishnaS, et al.Paired D10A Cas9 nickases are sometimes more efficient than individual nucleases for gene disruption. Nucleic Acids Res, 2018; 46(12):e71; doi: 10.1093/nar/gky222
13.
MirA, AltermanJF, HasslerMR, et al.Heavily and fully modified RNAs guide efficient SpyCas9-mediated genome editing. Nat Commun, 2018; 9(1):2641; doi: 10.1038/s41467-018-05073-z
14.
YinH, SongCQ, SureshS, et al.Structure-guided chemical modification of guide RNA enables potent non-viral in vivo genome editing. Nat Biotechnol, 2017; 35(12):1179–1187; doi: 10.1038/nbt.4005
15.
ZhangY, WangQ, WangJ, et al.Chemical modification and transformation strategies of guide RNAs in CRISPR-Cas9 gene editing systems. Chempluschem, 2021; 86(4):587–600; doi: 10.1002/cplu.202000785
16.
BasilaM, KelleyML, SmithAVB. Minimal 2’-O-methyl phosphorothioate linkage modification pattern of synthetic guide RNAs for increased stability and efficient CRISPR-Cas9 gene editing avoiding cellular toxicity. PLoS One, 2017; 12(11):e0188593; doi: 10.1371/journal.pone.0188593
17.
RyanDE, TaussigD, SteinfeldI, et al.Improving CRISPR-Cas specificity with chemical modifications in single-guide RNAs. Nucleic Acids Res, 2018; 46(2):792–803; doi: 10.1093/nar/gkx1199
18.
BoccalettoP, StefaniakF, RayA, et al.MODOMICS: A database of RNA modification pathways. 2021 update. Nucleic Acids Res, 2021; 50(D1):D231–D235; doi: 10.1093/nar/gkab1083
SuzukiT. The expanding world of tRNA modifications and their disease relevance. Nat Rev Mol Cell Biol, 2021; 22(6):375–392; doi: 10.1038/s41580-021-00342-0
21.
KumarS, MohapatraT. Deciphering epitranscriptome: Modification of mRNA bases provides a new perspective for post-transcriptional regulation of gene expression. Front Cell Dev Biol, 2021; 9:628415; doi: 10.3389/fcell.2021.628415
22.
KarijolichJ, YuYT. Spliceosomal snRNA modifications and their function. RNA Biol, 2010; 7(2):192–204; doi: 10.4161/rna.7.2.11207
23.
ThüringK, SchmidK, KellerP, et al.Analysis of RNA modifications by liquid chromatography–tandem mass spectrometry. Methods, 2016; 107:48–56; doi: 10.1016/j.ymeth.2016.03.019
24.
ChanCT, DyavaiahM, DeMottMS, et al.A quantitative systems approach reveals dynamic control of tRNA modifications during cellular stress. PLoS Genet, 2010; 6(12):e1001247; doi: 10.1371/journal.pgen.1001247
25.
AndersC, JinekM. In vitro enzymology of Cas9. Methods Enzymol, 2014; 546:1–20; doi: 10.1016/B978-0-12-801185-0.00001-5
26.
SambrookJ, RussellDW. Phosphorylating the 5’ termini of oligonucleotides. CSH Protoc, 2006; 2006(1):pdb.prot3880; doi: 10.1101/pdb.prot3880
27.
ShubsdaMF, GoodismanJ, DabrowiakJC. Quantitation of ethidium-stained closed circular DNA in agarose gels. J Biochem Biophys Methods, 1997; 34(1):73–79; doi: 10.1016/s0165-022x(96)01204-3
28.
StepanovG, ZhuravlevE, ShenderV, et al.Nucleotide modifications decrease innate immune response induced by synthetic analogs of snRNAs and snoRNAs. Genes, 2018; 9(11):531; doi: 10.3390/genes9110531
29.
KarikóK, MuramatsuH, WelshFA, et al.Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Mol Ther, 2008; 16(11):1833–1840; doi: 10.1038/mt.2008.200
30.
KarikóK, BucksteinM, NiH, et al.Suppression of RNA recognition by toll-like receptors: The impact of nucleoside modification and the evolutionary origin of RNA. Immunity, 2005; 23(2):165–175; doi: 10.1016/j.immuni.2005.06.008
31.
LiuY, NieH, SunR, et al.Enhancement of synthetic mRNA translation efficiency through engineered poly(A) tails. bioRxiv, 2021; 08.30.458298; doi: 10.1101/2021.08.30.458298
32.
AndersonBR, MuramatsuH, NallagatlaSR, et al.Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation. Nucleic Acids Res, 2010; 38(17):5884–5892; doi: 10.1093/nar/gkq347
33.
ChangJS, LinZX, LiuYJ, et al.Ultra performance liquid chromatography–tandem mass spectrometry assay for the quantification of RNA and DNA methylation. J Pharm Biomed Anal, 2021; 197:113969; doi: 10.1016/j.jpba.2021.113969
34.
KogakiT, OhshioI, UraH, et al.Development of a highly sensitive method for the quantitative analysis of modified nucleosides using UHPLC-UniSpray-MS/MS. J Pharm Biomed Anal, 2021; 197:113943; doi: 10.1016/j.jpba.2021.113943
35.
HarringtonLB, MaE, ChenJS, et al.A scoutRNA is required for some type V CRISPR-Cas systems. Mol Cell, 2020; 79(3):416.e5–424.e5; doi: 10.1016/j.molcel.2020.06.022
36.
LiuY, PintoF, WanX, et al.Reprogrammed tracrRNAs enable repurposing RNAs as crRNAs and detecting RNAs. Nat Commun, 2022; 13(1):1937; doi: 10.1038/s41467-022-29604-x
37.
ScottT, UrakR, SoemardyC, et al.Improved Cas9 activity by specific modifications of the tracrRNA. Sci Rep, 2019; 9(1):16104; doi: 10.1038/s41598-019-52616-5
38.
DavisDR. Stabilization of RNA stacking by pseudouridine. Nucleic Acids Res, 1995; 23(24):5020–5026; doi: 10.1093/nar/23.24.5020
39.
NewbyMI, GreenbaumNL. Investigation of Overhauser effects between pseudouridine and water protons in RNA helices. Proc Natl Acad Sci U S A, 2002; 99(20):12697–12702; doi: 10.1073/pnas.202477199
40.
StojicL, LunATL, MangeiJ, et al.Specificity of RNAi, LNA and CRISPRi as loss-of-function methods in transcriptional analysis. Nucleic Acids Res, 2018; 46(12):5950–5966; doi: 10.1093/nar/gky437
41.
KartjeZJ, BarkauCL, RohillaKJ, et al.Chimeric guides probe and enhance Cas9 biochemical activity. Biochemistry, 2018; 57(21):3027–3031; doi: 10.1021/acs.biochem.8b00107
42.
MitchellBP, HsuRV, MedranoMA, et al.Spontaneous embedding of DNA mismatches within the RNA:DNA hybrid of CRISPR-Cas9. Front Mol Biosci, 2020; 7:39; doi: 10.3389/fmolb.2020.00039
SioudM, FursetG, CekaiteL. Suppression of immunostimulatory siRNA-driven innate immune activation by 2’-modified RNAs. Biochem Biophys Res Commun, 2007; 361(1):122–126; doi: 10.1016/j.bbrc.2007.06.177
45.
DurbinAF, WangC, MarcotrigianoJ, et al.RNAs containing modified nucleotides fail to trigger RIG-I conformational changes for innate immune signaling. mBio, 2016; 7(5):e00833-16; doi: 10.1128/mBio.00833-16
46.
NushtaevaAA, StepanovGA, SemenovDV, et al.Characterization of primary normal and malignant breast cancer cell and their response to chemotherapy and immunostimulatory agents. BMC Cancer, 2018; 18(1):1–11; doi: 10.1186/s12885-018-4635-8
47.
RoostC, LynchSR, BatistaPJ, et al.Structure and thermodynamics of N6-methyladenosine in RNA: A spring-loaded base modification. J Am Chem Soc, 2015; 137(5):2107; doi: 10.1021/ja513080v
48.
SullivanNT, AllenAG, AtkinsAJ, et al.Designing safer CRISPR/Cas9 therapeutics for HIV: Defining factors that regulate and technologies used to detect off-target editing. Front Microbiol, 2020; 11:1872; doi: 10.3389/fmicb.2020.01872
49.
RaperAT, StephensonAA, SuoZ. Functional insights revealed by the kinetic mechanism of CRISPR/Cas9. J Am Chem Soc, 2018; 140(8):2971–2984; doi: 10.1021/jacs.7b13047
50.
VaidyanathanPP, AlsadhanI, MerrimanDK, et al.Pseudouridine and N6-methyladenosine modifications weaken PUF protein/RNA interactions. RNA, 2017; 23(5):611–618; doi: 10.1261/rna.060053.116
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
